title: Secondary leukemia after autologous peripheral blood progenitor cell transplantation for breast cancer.
authors.forename: S
authors.initials: S
authors.lastname: Sica
authors.forename: P
authors.initials: P
authors.lastname: Salutari
authors.forename: M
authors.initials: M
authors.lastname: Ciarli
authors.forename: N
authors.initials: N
authors.lastname: Piccirillo
authors.forename: L
authors.initials: L
authors.lastname: Laurenti
authors.forename: G
authors.initials: G
authors.lastname: Menichella
authors.forename: G
authors.initials: G
authors.lastname: Leone
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D003520:Cyclophosphamide / Q000009:adverse effects; D015251:Epirubicin / Q000009:adverse effects; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced*; D016609:Neoplasms, Second Primary / Q000139:chemically induced*
chemical_list: D015251:Epirubicin; D003520:Cyclophosphamide; D005472:Fluorouracil